JONES DAY TALKS®: International Litigation: Confidentiality and Legal Privilege under French Law
JONES DAY TALKS®: Private Antitrust Litigation in France
Compliance Perspectives: The French AFA on their Anti-Corruption Activities and Guidance ("Sapin 2 Law")
JONES DAY PRESENTS®: Trade Secret Enforcement in France
FCPA Compliance Report-Special Airbus Series-Cecilia Fellouse-Guenkel, the French Perspective
Podcast: Digital Taxation—Implications for EU Technology Companies
Everything Compliance-Episode 3
FCPA Compliance Report-Episode 293, Saskia Zandieh on the new French Anti-Corruption law, Sapin II
As macroeconomic forces and geopolitical dynamics continue to shape the M&A and investment climate globally, health and life sciences transactions continue to remain high priority sectors presenting both high growth and...more
While the French Data Protection Authority (the "CNIL") has consistently emphasized the importance of protecting health data, there will be even more focus for 2023 with more investigations and sanctions in this sector. The...more
Répondant aux critiques émanant de la pratique, un arrêté en date du 20 janvier 2023 a modifié l'arrêté du 24 septembre 2020 portant sur la typologie thématique des avantages et des conventions en application de l'article...more
More than two years after the publication of the ministerial order of 24 September 2020 establishing a “thematic typology” of benefits and agreements provided for in Article R1453-14 of the French Public Health Code, a...more
Analysis and update on a possible major evolution of the regulation applicable to telemedicine, currently borne by the Social Security Financing Bill for 2023 and being discussed by the French Parliament. The Social Security...more
Analyse et point d’étape concernant une possible évolution majeure de la règlementation applicable aux actes de télémédecine qui est actuellement portée par le PLFSS 2023 et en cours de discussion devant le Parlement - Le...more
Dans un rapport publié le 23 juin 2021, la mission d’information sur les médicaments de l’Assemblée préconise notamment la création d’un haut-commissaire aux produits de santé dont on peut légitimement se demander s’il sera...more
Les textes réglementaires d’application du nouveau dispositif d’accès précoce au 1er juillet ont été publiés. Les dispositions se veulent précises sur le cadre juridique d’instruction des demandes et la HAS et l’ANSM...more
Given the growing number of digital tools that can be used in healthcare, the French National Authority for Health (HAS) has recently developed a system for classifying digital healthcare solutions according to their purpose...more
2020 marks a further milestone in stricter controls on HCPs interactions in France. French government has laid the remaining bricks for the new (and stricter) regulatory framework for interactions between the industry and...more
On 20 December 2017, the French Competition Authority (the FCA) imposed a EUR 25 million fine on a pharmaceutical laboratory, for delaying entry onto the market of the generic version of Durogesic, and for hindering its...more
The French sunshine regulations require industry to report certain agreements along with the fees and other benefits provided to various stakeholders in the healthcare sector. ...more
The Paris office of Hogan Lovells is pleased to provide this English language edition of our monthly e-newsletter, which offers a legal and regulatory update covering France and Europe for February 2017. Commercial Law -...more
The Paris office of Hogan Lovells is pleased to provide this English language edition of our monthly e-newsletter, which offers a legal and regulatory update covering France and Europe for January 2017. 1. Audovisual...more
On 19 January 2017, major modifications were adopted in France to the regulations on interactions between the industry and healthcare professionals (and other stakeholders). These new regulations, a.k.a. "anti-benefits...more
Law no. 2011-2012 of 29 December 2011, also known as the French Sunshine Act, introduced into French law disclosure obligations imposed on health care companies (HCC). The French Medical Board and a nonprofit organisation...more